(1 - 9 von 10
)
Veloxis Announces Senior Level Appointments in Preparation for U.S....
www.finanznachrichten.de
Vincenza Nigro continues to lead the medical affairs activities for Veloxis. Ms. Nigro has extensive transplant experience from her prior work at ...
Hansa Medical Announces Appointment of Vincenza Nigro as Vice...
view.news.eu.nasdaq.com
... enzymes for organ transplantation and acute autoimmune conditions, today announced the appointment of Vincenza Nigro as Vice President ...
Phase III Clinical Study Data Demonstrating LCP-Tacro™’s Comparable...
www.eqs-news.com
Phase III Clinical Study Data Demonstrating LCP-Tacro™’s Comparable Efficacy and Safety to Twice-Daily Tacrolimus Presented at the European Society...
2009 CureSearch Annual Report
content.yudu.com
Mr. and Mrs. Arnold O. Helms Ms. Vincenza Nigro Ms. Linda A. Wadler Mr. and Mrs. Patrick Heinzle Mr. and Mrs. Patrick E. Norris Mr. and Mrs. Thomas L.
Phase III Clinical Study Data Demonstrating LCP-Tacro™’s
www.globenewswire.com
Company Announcement no To: NASDAQ OMX Copenhagen A/S Hørsholm, Denmark, 4 September...
Veloxis Announces Senior Level Appointments in DGAPwww.dgap.de › dgap › News › corporate › veloxis-announces-senior-level-a...
www.eqs-news.com
Vincenza Nigro continues to lead the medical affairs activities for Veloxis. Ms. Nigro has extensive transplant experience from her prior work at ...
sortiert nach Relevanz / Datum